These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 195569)

  • 1. Actions of cholinergic agonist and antagonists on the adrenocortical response of basal, hypoxic, and hypercapnic rats.
    Marotta SF; Sithichoke N
    Aviat Space Environ Med; 1977 May; 48(5):446-50. PubMed ID: 195569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocortical responses of rats to acute hypoxic and hypercapnic stresses after treatment with aminergic agents.
    Marotta SF; Sithichoke N; Garcy AM; Yu M
    Neuroendocrinology; 1976; 20(2):182-92. PubMed ID: 183164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic influences on hypothalamic-pituitary-adrenocortical activity of stressed rats: an approach utilizing agonists and antagonists.
    Sithichoke N; Marotta SF
    Acta Endocrinol (Copenh); 1978 Dec; 89(4):726-36. PubMed ID: 716778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the stimulatory action of nicotine on adrenocortical function in the rat.
    Weidenfeld J; Bodoff M; Saphier D; Brenner T
    Neuroendocrinology; 1989 Aug; 50(2):132-8. PubMed ID: 2550835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholinergic and anticholinergic drugs and a partial cholinergic agonist on the development and expression of physical dependence on morphine in rat.
    Frederickson RC; Pinsky C
    J Pharmacol Exp Ther; 1975 Apr; 193(1):44-55. PubMed ID: 1169318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic drugs and 4-aminopyridine alter hypoxic-induced behavioral deficits.
    Gibson GE; Pelmas CJ; Peterson C
    Pharmacol Biochem Behav; 1983 Jun; 18(6):909-16. PubMed ID: 6136988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholinergic agonists and antagonists on jumping behaviour induced by morphine and L-dopa in mice.
    Pillai NP; Ramaswamy S; Gopalakrishnan V; Ghosh MN
    Indian J Exp Biol; 1984 Jan; 22(1):59-60. PubMed ID: 6746026
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma cortisol of conscious cats during cerebroventricular perfusion with adrenergic, cholinergic and gabanergic antagonists.
    Garcy AM; Marotta SF
    Neuroendocrinology; 1978; 25(6):343-53. PubMed ID: 662081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid induction of supersensitivity to muscarinic antagonists-induced motor excitation by continuous stimulation of cholinergic receptors.
    Fernando JC; Hoskins B; Ho IK
    Life Sci; 1985 Sep; 37(9):883-92. PubMed ID: 4041002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic mechanisms and cataplexy in dogs.
    Delashaw JB; Foutz AS; Guilleminault C; Dement WC
    Exp Neurol; 1979 Dec; 66(3):745-57. PubMed ID: 573697
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of cholinergic agonists and antagonists on self-stimulation behavior in the rat.
    Newman LM
    J Comp Physiol Psychol; 1972 Jun; 79(3):394-413. PubMed ID: 5054476
    [No Abstract]   [Full Text] [Related]  

  • 12. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pituitary-adrenocortical system in mediating avoidance behavior of rats with septal lesions.
    Kelsey JE
    J Comp Physiol Psychol; 1975 Jan; 88(1):271-80. PubMed ID: 164487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of peripheral cholinergic activation on the adrenal cortex function.
    Kolta MG; Soliman KF
    Endocr Res Commun; 1981; 8(4):239-46. PubMed ID: 7338212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
    Witkin JM
    Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic agonist-antagonist interactions on neocortical and limbic EEG activation.
    Yamamoto KI; Domino EF
    Int J Neuropharmacol; 1967 Sep; 6(5):357-73. PubMed ID: 6069723
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of muscarinic pharmacophores on the cholinergic regulation of catecholamine secretion from perfused adrenal glands.
    Nakazato Y; Oleshansky MA; Chiang PK
    Arch Int Pharmacodyn Ther; 1988; 293():209-18. PubMed ID: 3421778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists.
    Bhargava HN; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):79-88. PubMed ID: 944135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditioned gustatory avoidance induced by three cholinergic agents.
    Preston KL; Schuster CR
    Pharmacol Biochem Behav; 1981 Nov; 15(5):827-8. PubMed ID: 7312919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic and cholinergic interaction in the regulation of pituitary-adrenal function in rats.
    Kile JP; Turner BB
    Experientia; 1985 Sep; 41(9):1123-7. PubMed ID: 4043317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.